[Efficacy and prognosis of PAD combination therapy for fifty-six previously untreated patients with multiple myeloma]

Zhonghua Xue Ye Xue Za Zhi. 2016 Jun 14;37(6):520-2. doi: 10.3760/cma.j.issn.0253-2727.2016.06.016.
[Article in Chinese]
No abstract available

MeSH terms

  • Bortezomib / therapeutic use*
  • Dexamethasone / therapeutic use*
  • Doxorubicin / therapeutic use*
  • Drug Therapy, Combination
  • Humans
  • Multiple Myeloma / drug therapy*
  • Prognosis

Substances

  • Bortezomib
  • Dexamethasone
  • Doxorubicin

Grants and funding

基金项目:江苏省科教兴卫工程-临床医学中心(ZX201102);江苏省血液病临床医学研究中心(江苏省科技厅生命健康专项-BL2012005);国家临床重点专科建设项目;国家高技术研究发展计划(2012AA02A505)、卫生公益性行业科研专项(201202017)